SCHEMBL24978781

SCHEMBL24978781

CC[C@@]1(C)C(=O)OCc2c1cc1n(c2=O)Cc2cc3cc4c(cc3nc2-1)OCO4

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 18/20 0.79
DDX5 P17844 1/20 0.79
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
KDM4E B2RXH2 3/20 0.58
ALDH1A1 P00352 3/20 0.58
CYP3A4 P08684 2/20 0.58
HBB P68871 2/20 0.58
CASP1 P29466 1/20 0.58
CASP7 P55210 1/20 0.58
TP53 P04637 2/20 0.57
GLA P06280 2/20 0.57
HPGD P15428 2/20 0.57
STAT6 P42226 1/20 0.57
CHEK1 O14757 1/20 0.57
HDAC3 O15379 1/20 0.57
ABCC4 O15439 1/20 0.57
GMNN O75496 1/20 0.57
LMNA P02545 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30255916 0.88 TOP1 (1.00) TOP1DDX5MEN1KMT2ASMN1; SMN2
SCHEMBL29429769 0.88 TOP1 (1.00) TOP1DDX5MEN1KMT2ASMN1; SMN2
SCHEMBL20286453 0.88 TOP1 (1.00) TOP1DDX5MEN1KMT2ASMN1; SMN2
SCHEMBL18296600 0.88 TOP1 (1.00) TOP1DDX5MEN1KMT2ASMN1; SMN2
SCHEMBL9563404 0.88 TOP1 (1.00) TOP1DDX5MEN1KMT2ASMN1; SMN2
SCHEMBL29473358 0.88 TOP1 (1.00) TOP1DDX5MEN1KMT2ASMN1; SMN2
SCHEMBL27407822 0.86 TOP1 (0.78) TOP1DDX5MEN1KMT2ASMN1; SMN2
SCHEMBL25129440 0.85 TOP1 (0.77) TOP1DDX5MEN1KMT2ASMN1; SMN2
SCHEMBL25129742 0.85 TOP1 (0.77) TOP1DDX5MEN1KMT2ASMN1; SMN2
SCHEMBL8194838 0.85 TOP1 (0.78) TOP1MEN1KMT2ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230036256-A1 CAMPTOTHECIN CONJUGATES SEAGEN INC. 2023-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230036256-A1 CAMPTOTHECIN CONJUGATES DCLRE1A, TOP2A, PAICS TOP1 4/4885DDX5 2703/4885MEN1 636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.